Global Therapeutic Nuclear Medicines Market Research Report 2025(Status and Outlook)
Description
Report Overview
Therapeutic nuclear medicines are radiopharmaceuticals used for treating diseases by delivering targeted radiation to specific cells or tissues, primarily in oncology, cardiology, and neurology. These medicines incorporate radioactive isotopes, such as lutetium-177, iodine-131, or yttrium-90, which emit therapeutic radiation to destroy malignant cells while minimizing damage to surrounding healthy tissue. Applications include treating thyroid cancer, neuroendocrine tumors, bone metastases, and certain hematologic malignancies. The market is driven by increasing cancer prevalence, advancements in radiopharmaceutical development, and the growing adoption of targeted therapies. Key players focus on expanding indications, improving drug delivery systems, and integrating diagnostic and therapeutic capabilities (theranostics). Regulatory approvals, reimbursement policies, and supply chain challenges for radioactive isotopes influence market dynamics. Geographically, North America and Europe dominate due to established healthcare infrastructure, while Asia-Pacific shows rapid growth due to rising healthcare investment and awareness.
The global Therapeutic Nuclear Medicines market size was estimated at USD 2336.47 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 18.18% during the forecast period.
This report provides a deep insight into the global Therapeutic Nuclear Medicines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Therapeutic Nuclear Medicines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Therapeutic Nuclear Medicines market in any manner.
Global Therapeutic Nuclear Medicines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis AG
Bayer
China Isotope and Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes
Market Segmentation (by Type)
Radium-223
Lutetium-177
Iodine-131
Other
Market Segmentation (by Application)
Thyroid
Bone Metastasis
Lymphoma
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Therapeutic Nuclear Medicines Market
Overview of the regional outlook of the Therapeutic Nuclear Medicines Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Therapeutic Nuclear Medicines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Therapeutic Nuclear Medicines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Therapeutic nuclear medicines are radiopharmaceuticals used for treating diseases by delivering targeted radiation to specific cells or tissues, primarily in oncology, cardiology, and neurology. These medicines incorporate radioactive isotopes, such as lutetium-177, iodine-131, or yttrium-90, which emit therapeutic radiation to destroy malignant cells while minimizing damage to surrounding healthy tissue. Applications include treating thyroid cancer, neuroendocrine tumors, bone metastases, and certain hematologic malignancies. The market is driven by increasing cancer prevalence, advancements in radiopharmaceutical development, and the growing adoption of targeted therapies. Key players focus on expanding indications, improving drug delivery systems, and integrating diagnostic and therapeutic capabilities (theranostics). Regulatory approvals, reimbursement policies, and supply chain challenges for radioactive isotopes influence market dynamics. Geographically, North America and Europe dominate due to established healthcare infrastructure, while Asia-Pacific shows rapid growth due to rising healthcare investment and awareness.
The global Therapeutic Nuclear Medicines market size was estimated at USD 2336.47 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 18.18% during the forecast period.
This report provides a deep insight into the global Therapeutic Nuclear Medicines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Therapeutic Nuclear Medicines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Therapeutic Nuclear Medicines market in any manner.
Global Therapeutic Nuclear Medicines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis AG
Bayer
China Isotope and Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes
Market Segmentation (by Type)
Radium-223
Lutetium-177
Iodine-131
Other
Market Segmentation (by Application)
Thyroid
Bone Metastasis
Lymphoma
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Therapeutic Nuclear Medicines Market
Overview of the regional outlook of the Therapeutic Nuclear Medicines Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Therapeutic Nuclear Medicines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Therapeutic Nuclear Medicines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
144 Pages
- 1 Research Methodology And Statistical Scope
- 1.1 Market Definition And Statistical Scope Of Therapeutic Nuclear Medicines
- 1.2 Key Market Segments
- 1.2.1 Therapeutic Nuclear Medicines Segment By Type
- 1.2.2 Therapeutic Nuclear Medicines Segment By Application
- 1.3 Methodology & Sources Of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown And Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Therapeutic Nuclear Medicines Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Therapeutic Nuclear Medicines Market Size (M Usd) Estimates And Forecasts (2020-2033)
- 2.1.2 Global Therapeutic Nuclear Medicines Sales Estimates And Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size By Region
- 3 Therapeutic Nuclear Medicines Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Therapeutic Nuclear Medicines Product Life Cycle
- 3.3 Global Therapeutic Nuclear Medicines Sales By Manufacturers (2020-2025)
- 3.4 Global Therapeutic Nuclear Medicines Revenue Market Share By Manufacturers (2020-2025)
- 3.5 Therapeutic Nuclear Medicines Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.6 Global Therapeutic Nuclear Medicines Average Price By Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, And Product Types
- 3.8 Therapeutic Nuclear Medicines Market Competitive Situation And Trends
- 3.8.1 Therapeutic Nuclear Medicines Market Concentration Rate
- 3.8.2 Global 5 And 10 Largest Therapeutic Nuclear Medicines Players Market Share By Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Therapeutic Nuclear Medicines Industry Chain Analysis
- 4.1 Therapeutic Nuclear Medicines Industry Chain Analysis
- 4.2 Market Overview Of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development And Dynamics Of Therapeutic Nuclear Medicines Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 Pest Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Therapeutic Nuclear Medicines Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions And Their Impacts To Therapeutic Nuclear Medicines Market
- 5.7 Esg Ratings Of Leading Companies
- 6 Therapeutic Nuclear Medicines Market Segmentation By Type
- 6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
- 6.2 Global Therapeutic Nuclear Medicines Sales Market Share By Type (2020-2025)
- 6.3 Global Therapeutic Nuclear Medicines Market Size Market Share By Type (2020-2025)
- 6.4 Global Therapeutic Nuclear Medicines Price By Type (2020-2025)
- 7 Therapeutic Nuclear Medicines Market Segmentation By Application
- 7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
- 7.2 Global Therapeutic Nuclear Medicines Market Sales By Application (2020-2025)
- 7.3 Global Therapeutic Nuclear Medicines Market Size (M Usd) By Application (2020-2025)
- 7.4 Global Therapeutic Nuclear Medicines Sales Growth Rate By Application (2020-2025)
- 8 Therapeutic Nuclear Medicines Market Sales By Region
- 8.1 Global Therapeutic Nuclear Medicines Sales By Region
- 8.1.1 Global Therapeutic Nuclear Medicines Sales By Region
- 8.1.2 Global Therapeutic Nuclear Medicines Sales Market Share By Region
- 8.2 Global Therapeutic Nuclear Medicines Market Size By Region
- 8.2.1 Global Therapeutic Nuclear Medicines Market Size By Region
- 8.2.2 Global Therapeutic Nuclear Medicines Market Size Market Share By Region
- 8.3 North America
- 8.3.1 North America Therapeutic Nuclear Medicines Sales By Country
- 8.3.2 North America Therapeutic Nuclear Medicines Market Size By Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Therapeutic Nuclear Medicines Sales By Country
- 8.4.2 Europe Therapeutic Nuclear Medicines Market Size By Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Therapeutic Nuclear Medicines Sales By Region
- 8.5.2 Asia Pacific Therapeutic Nuclear Medicines Market Size By Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Therapeutic Nuclear Medicines Sales By Country
- 8.6.2 South America Therapeutic Nuclear Medicines Market Size By Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East And Africa
- 8.7.1 Middle East And Africa Therapeutic Nuclear Medicines Sales By Region
- 8.7.2 Middle East And Africa Therapeutic Nuclear Medicines Market Size By Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 Uae Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Therapeutic Nuclear Medicines Market Production By Region
- 9.1 Global Production Of Therapeutic Nuclear Medicines By Region(2020-2025)
- 9.2 Global Therapeutic Nuclear Medicines Revenue Market Share By Region (2020-2025)
- 9.3 Global Therapeutic Nuclear Medicines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.4 North America Therapeutic Nuclear Medicines Production
- 9.4.1 North America Therapeutic Nuclear Medicines Production Growth Rate (2020-2025)
- 9.4.2 North America Therapeutic Nuclear Medicines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.5 Europe Therapeutic Nuclear Medicines Production
- 9.5.1 Europe Therapeutic Nuclear Medicines Production Growth Rate (2020-2025)
- 9.5.2 Europe Therapeutic Nuclear Medicines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.6 Japan Therapeutic Nuclear Medicines Production (2020-2025)
- 9.6.1 Japan Therapeutic Nuclear Medicines Production Growth Rate (2020-2025)
- 9.6.2 Japan Therapeutic Nuclear Medicines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.7 China Therapeutic Nuclear Medicines Production (2020-2025)
- 9.7.1 China Therapeutic Nuclear Medicines Production Growth Rate (2020-2025)
- 9.7.2 China Therapeutic Nuclear Medicines Production, Revenue, Price And Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Novartis Ag
- 10.1.1 Novartis Ag Basic Information
- 10.1.2 Novartis Ag Therapeutic Nuclear Medicines Product Overview
- 10.1.3 Novartis Ag Therapeutic Nuclear Medicines Product Market Performance
- 10.1.4 Novartis Ag Business Overview
- 10.1.5 Novartis Ag Swot Analysis
- 10.1.6 Novartis Ag Recent Developments
- 10.2 Bayer
- 10.2.1 Bayer Basic Information
- 10.2.2 Bayer Therapeutic Nuclear Medicines Product Overview
- 10.2.3 Bayer Therapeutic Nuclear Medicines Product Market Performance
- 10.2.4 Bayer Business Overview
- 10.2.5 Bayer Swot Analysis
- 10.2.6 Bayer Recent Developments
- 10.3 China Isotope And Radiation
- 10.3.1 China Isotope And Radiation Basic Information
- 10.3.2 China Isotope And Radiation Therapeutic Nuclear Medicines Product Overview
- 10.3.3 China Isotope And Radiation Therapeutic Nuclear Medicines Product Market Performance
- 10.3.4 China Isotope And Radiation Business Overview
- 10.3.5 China Isotope And Radiation Swot Analysis
- 10.3.6 China Isotope And Radiation Recent Developments
- 10.4 Q Biomed
- 10.4.1 Q Biomed Basic Information
- 10.4.2 Q Biomed Therapeutic Nuclear Medicines Product Overview
- 10.4.3 Q Biomed Therapeutic Nuclear Medicines Product Market Performance
- 10.4.4 Q Biomed Business Overview
- 10.4.5 Q Biomed Recent Developments
- 10.5 Curium Pharmaceuticals
- 10.5.1 Curium Pharmaceuticals Basic Information
- 10.5.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Overview
- 10.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Market Performance
- 10.5.4 Curium Pharmaceuticals Business Overview
- 10.5.5 Curium Pharmaceuticals Recent Developments
- 10.6 Jubilant Draximage
- 10.6.1 Jubilant Draximage Basic Information
- 10.6.2 Jubilant Draximage Therapeutic Nuclear Medicines Product Overview
- 10.6.3 Jubilant Draximage Therapeutic Nuclear Medicines Product Market Performance
- 10.6.4 Jubilant Draximage Business Overview
- 10.6.5 Jubilant Draximage Recent Developments
- 10.7 Dongcheng
- 10.7.1 Dongcheng Basic Information
- 10.7.2 Dongcheng Therapeutic Nuclear Medicines Product Overview
- 10.7.3 Dongcheng Therapeutic Nuclear Medicines Product Market Performance
- 10.7.4 Dongcheng Business Overview
- 10.7.5 Dongcheng Recent Developments
- 10.8 Lantheus
- 10.8.1 Lantheus Basic Information
- 10.8.2 Lantheus Therapeutic Nuclear Medicines Product Overview
- 10.8.3 Lantheus Therapeutic Nuclear Medicines Product Market Performance
- 10.8.4 Lantheus Business Overview
- 10.8.5 Lantheus Recent Developments
- 10.9 Acrotech Biopharma.
- 10.9.1 Acrotech Biopharma. Basic Information
- 10.9.2 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Overview
- 10.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Market Performance
- 10.9.4 Acrotech Biopharma. Business Overview
- 10.9.5 Acrotech Biopharma. Recent Developments
- 10.10 Progenics Pharmaceuticals
- 10.10.1 Progenics Pharmaceuticals Basic Information
- 10.10.2 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Overview
- 10.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Market Performance
- 10.10.4 Progenics Pharmaceuticals Business Overview
- 10.10.5 Progenics Pharmaceuticals Recent Developments
- 10.11 International Isotopes
- 10.11.1 International Isotopes Basic Information
- 10.11.2 International Isotopes Therapeutic Nuclear Medicines Product Overview
- 10.11.3 International Isotopes Therapeutic Nuclear Medicines Product Market Performance
- 10.11.4 International Isotopes Business Overview
- 10.11.5 International Isotopes Recent Developments
- 11 Therapeutic Nuclear Medicines Market Forecast By Region
- 11.1 Global Therapeutic Nuclear Medicines Market Size Forecast
- 11.2 Global Therapeutic Nuclear Medicines Market Forecast By Region
- 11.2.1 North America Market Size Forecast By Country
- 11.2.2 Europe Therapeutic Nuclear Medicines Market Size Forecast By Country
- 11.2.3 Asia Pacific Therapeutic Nuclear Medicines Market Size Forecast By Region
- 11.2.4 South America Therapeutic Nuclear Medicines Market Size Forecast By Country
- 11.2.5 Middle East And Africa Forecasted Sales Of Therapeutic Nuclear Medicines By Country
- 12 Forecast Market By Type And By Application (2026-2033)
- 12.1 Global Therapeutic Nuclear Medicines Market Forecast By Type (2026-2033)
- 12.1.1 Global Forecasted Sales Of Therapeutic Nuclear Medicines By Type (2026-2033)
- 12.1.2 Global Therapeutic Nuclear Medicines Market Size Forecast By Type (2026-2033)
- 12.1.3 Global Forecasted Price Of Therapeutic Nuclear Medicines By Type (2026-2033)
- 12.2 Global Therapeutic Nuclear Medicines Market Forecast By Application (2026-2033)
- 12.2.1 Global Therapeutic Nuclear Medicines Sales (K Mt) Forecast By Application
- 12.2.2 Global Therapeutic Nuclear Medicines Market Size (M Usd) Forecast By Application (2026-2033)
- 13 Conclusion And Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
